Dataset from A Multicenter, Single-arm, Open-label Trial to Evaluate Efficacy and Safety of Oral, Twice Daily Iptacopan in Adult PNH Patients Who Are Naive to Complement Inhibitor Therapy

NIAID Data Ecosystem2026-05-10 收录

PNH药物临床试验

补体抑制剂初治患者

数据链接：

https://doi.org/10.25934/PR00012935 数据链接链接失效反馈

官方服务：

资源简介：

The purpose of this Phase 3 study was to determine whether iptacopan is efficacious and safe for the treatment of Paroxysmal nocturnal hemoglobinuria (PNH) patients who were naïve to complement inhibitor therapy.

创建时间：

2026-03-27

Dataset from A Multicenter, Single-arm, Open-label Trial to Evaluate Efficacy and Safety of Oral, Twice Daily Iptacopan in Adult PNH Patients Who Are Naive to Complement Inhibitor Therapy

资源简介：

相关数据集